AGEN
Agenus (AGEN)
$92
About Agenus (AGEN)
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Details
Daily high
$3.00
Daily low
$2.83
Price at open
$2.83
52 Week High
$7.34
52 Week Low
$1.38
Market cap
99.3M
Dividend yield
0.00%
Volume
280,692
Avg. volume
557,534
P/E ratio
-1.37
Agenus News
Details
Daily high
$3.00
Daily low
$2.83
Price at open
$2.83
52 Week High
$7.34
52 Week Low
$1.38
Market cap
99.3M
Dividend yield
0.00%
Volume
280,692
Avg. volume
557,534
P/E ratio
-1.37